메뉴 건너뛰기




Volumn , Issue , 2011, Pages

Tuberculosis complicated by immune reconstitution inflammatory syndrome in a patient on anti-TNFα therapy for Crohn's disease

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; INFLIXIMAB; PREDNISOLONE; TUBERCULOSTATIC AGENT;

EID: 79955392946     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.09.2010.3376     Document Type: Article
Times cited : (12)

References (12)
  • 1
    • 65449123539 scopus 로고    scopus 로고
    • Differentiating intestinal tuberculosis from Crohn's disease: A diagnostic challenge
    • Almadi MA, Ghosh S, Aljebreen AM. Differentiating intestinal tuberculosis from Crohn's disease: a diagnostic challenge. Am J Gastroenterol 2009;104:1003-12.
    • (2009) Am J Gastroenterol , vol.104 , pp. 1003-1012
    • Almadi, M.A.1    Ghosh, S.2    Aljebreen, A.M.3
  • 2
    • 77949273279 scopus 로고    scopus 로고
    • Clinical, endoscopic, and histological differentiations between Crohn's disease and intestinal tuberculosis
    • Makharia GK, Srivastava S, Das P, et al. Clinical, endoscopic, and histological differentiations between Crohn's disease and intestinal tuberculosis. Am J Gastroenterol 2010;105:642-51.
    • (2010) Am J Gastroenterol , vol.105 , pp. 642-651
    • Makharia, G.K.1    Srivastava, S.2    Das, P.3
  • 3
    • 0035846326 scopus 로고    scopus 로고
    • Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent
    • Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345:1098-104.
    • (2001) N Engl J Med , vol.345 , pp. 1098-1104
    • Keane, J.1    Gershon, S.2    Wise, R.P.3
  • 5
    • 25444517037 scopus 로고    scopus 로고
    • BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-{alpha} treatment
    • British Thoracic Society Standards of Care Committee
    • British Thoracic Society Standards of Care Committee. BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-{alpha} treatment. Thorax 2005;60(10):800-5.
    • (2005) Thorax , vol.60 , Issue.10 , pp. 800-805
  • 6
    • 64749087194 scopus 로고    scopus 로고
    • Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold in Tube assay, and T-Spot.TB test in contact investigations for tuberculosis
    • Diel R, Loddenkemper R, Meywald-Walter K, et al. Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot.TB test in contact investigations for tuberculosis. Chest 2009;135:1010-18.
    • (2009) Chest , vol.135 , pp. 1010-1018
    • Diel, R.1    Loddenkemper, R.2    Meywald-Walter, K.3
  • 8
    • 0036169930 scopus 로고    scopus 로고
    • Aspirin antiplatelet therapy and nonsteroidal antiinflammatory drugs: Comment on the 2002 update of the American College of Rheumatology Guidelines for the Management of Rheumatoid Arthritis
    • Pablos JL. Aspirin antiplatelet therapy and nonsteroidal antiinflammatory drugs: comment on the 2002 update of the American College of Rheumatology Guidelines for the Management of Rheumatoid Arthritis. Arthritis Rheum 2002;46:328-46.
    • (2002) Arthritis Rheum , vol.46 , pp. 328-346
    • Pablos, J.L.1
  • 10
    • 33747336276 scopus 로고    scopus 로고
    • Infliximab for rheumatoid arthritis in a patient with tuberculosis
    • Matsumoto T, Tanaka T, Kawase I. Infliximab for rheumatoid arthritis in a patient with tuberculosis. N Engl J Med 2006;355:740-1.
    • (2006) N Engl J Med , vol.355 , pp. 740-741
    • Matsumoto, T.1    Tanaka, T.2    Kawase, I.3
  • 11
    • 38149011457 scopus 로고    scopus 로고
    • Is it safe to readminister tumor necrosis factor alpha antagonists following tuberculosis flare?
    • Aslanidis S, Pyrpasopoulou A, Douma S, et al. Is it safe to readminister tumor necrosis factor alpha antagonists following tuberculosis flare? Arthritis Rheum 2008;58:327-8.
    • (2008) Arthritis Rheum , vol.58 , pp. 327-328
    • Aslanidis, S.1    Pyrpasopoulou, A.2    Douma, S.3
  • 12
    • 52049086818 scopus 로고    scopus 로고
    • Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes
    • Blackmore TK, Manning L, Taylor WJ, et al. Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes. Clin Infect Dis 2008;47:e83-5.
    • (2008) Clin Infect Dis , vol.47
    • Blackmore, T.K.1    Manning, L.2    Taylor, W.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.